End point Nesiritide Placebo p Peak SCr increase (mg/dL)  

Slides:



Advertisements
Similar presentations
Update in the management of AKI
Advertisements

Horng H Chen MD on behalf of the NHLBI Heart Failure Clinical Research Network Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF):
Mechanisms and Management in Acute Kidney Injury Paul Stevens Kent Kidney Care Centre.
Diabetic Nephropathy.  Over 40% of new cases of end-stage renal disease (ESRD) are attributed to diabetes.  In 2001, 41,312 people with diabetes began.
+ Case Study One Pediatric Patient’s Experience Shelley Chapman RN, BSN, CCTC Children’s Hospital of Wisconsin.
Renal function.
Kreatinine Verklaard !? Introductie. At what level of creatinine does a 65-year-old diabetic, hypertensive white woman weighing 50 kilograms have chronic.
0902CZR01NL537SS0901 RENAAL Altering the Course of Renal Disease in Hypertensive Patients with Type 2 Diabetes and Nephropathy with the A II Antagonist.
ARMYDA-CIN Trial [Atorvastatin for Reduction of Myocardial Damage during Angioplasty–Contrast-Induced Nephropathy]
Evaluation of Renal Function. Normal volumes and composition of electrolytes in various body fluid compartments are essential for maintenance of life.
4/9/08 Urinary System Chapter 24 – Day 4. 4/9/08 Renal Failure  Decrease or increase in normal renal function  Acute & Chronic – discussed in next few.
Objective: To utilize preclinical and phase I PK/PD data from a new quinolone (Q) and relevant public domain data to develop an exposure-response model.
The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT Systolic Heart failure.
Bicarbonate-Based Solutions in the Management of Acute Kidney Injury Vania Cecilia Prudencio-Ribera, MD 1 ; Universidad Mayor de San Simón, School of Medicine,
2-4. Estimated Renal Function Estimated GFR = 1.8 x (Cs) x (age) Cockcroft-Gault eq. – Estimated creatine clearance (mL/min) = (140 – age x body weight,
Background There are 12 different types of medications to lower blood sugar levels in patients with type 2 diabetes. It is widely agreed upon that metformin.
Renal Physiology and Function Part II Renal Function Tests
Trial profile Mann JF et al. Lancet 2008;372:
Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Long-term Risk of Mortality and End-Stage Renal Disease.
Anemia in CKD The TREAT Trial Reference Pfeiffer MA. A trial of Darbepoetin alpha in type II diabetes and chronic kidney disease. N Engl J Med. 2009;361:2019–2032.
Cardiovascular Disease and Antihypertensives The RENAAL Trial Reference Brunner BM, and the RENAAL study group. Effects of losartan on renal and cardiovascular.
신장내과 R4 강혜란 Cardiorenal syndrome (CRS).  Patients with heart failure (HF) who have a reduced GFR -> Mortality ↑  Patients with chronic kidney disease.
R1. 이용석 / modulator pf. 임천규. Introduction Autosomal dominant polycystic kidney disease (ADPKD) is characterized by gradual cyst enlargement over a period.
The Impact of Preoperative Renal Dysfunction on the Outcomes of Patients Undergoing Transcatheter Aortic Valve Replacement Andres M. Pineda MD, J. Kevin.
Stephen R. Ash, MD, FACP IU Health Arnett Lafayette, Indiana 2017
An AKI project for critically ill cancer patients
Clinical Outcomes with Newer Antihyperglycemic Agents
RIFLE criteria for acute kidney injury
SEPSIS COLLABORATIVE Clinical Measures Scorecard Classification
From: A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation Ann Intern Med. 1999;130(6):
New Diagnostic Criteria and Management of Acute Kidney Injury
Melody Sherwood, Peter A McCullough  The Lancet Global Health 
VA Cooperative Studies Program Trial # 578
Volume 1: Chronic Kidney Disease Chapter 5: Acute Kidney Injury
STUDY OF OBSTETRICAL ACUTE RENAL FAILURE IN A TERTIARY CARE CENTRE
Copyright © 2015 by the American Osteopathic Association.
Fig. 1. Distribution of eGFR according to baseline SCr
So What is Albuminuria? An elevated urinary albumin excretion is a marker of endothelial dysfunction that symbolizes the kidney’s way to translate the.
Sheldon Chen  Advances in Chronic Kidney Disease 
Median NT-proBNP levels (pg/mL) by GFR and 60-day survival
Objectives Early initiation of continuous renal replacement therapy
Renal function and outcome after heart transplantation
Systolic Heart failure treatment with the If inhibitor ivabradine Trial The effect of heart rate reduction with ivabradine on renal function in patients.
Change in mean serum creatinine, PAC-guided vs empiric therapy
2018 Annual Data Report Volume 1: Chronic Kidney Disease
Variable Pretreatment Posttreatment P GFR (mL/min) 115±18 102±14 NS
considering further dose(s)
TNT post hoc analysis: Improvement between baseline and final visit in estimated GFR by treatment group End point 10-mg atorvastatin 80-mg atorvastatin.
Creatinine clearance in cases and controls
Update on acute kidney injury after cardiac surgery
Management of Acute Kidney Injury: Core Curriculum 2018
Melody Sherwood, Peter A McCullough  The Lancet Global Health 
A contemporary experience of open aortic reconstruction in patients with chronic atherosclerotic occlusion of the abdominal aorta  Charles A. West, MD,
I. Introduction American Journal of Kidney Diseases
What’s Left of Physiology
Meeting the challenges of the new K/DOQI guidelines
J Foland, J Fortenberry, B Warshaw,
Changes in glomerular filtration rate after cardiac surgery with cardiopulmonary bypass in patients with mild preoperative renal dysfunction  B.G. Loef,
Volume 80, Issue 7, Pages (October 2011)
Welcome Ask The Experts March 24-27, 2007 New Orleans, LA.
Quiz Page July 2012 American Journal of Kidney Diseases
Etienne Macedo, Ravindra L. Mehta  American Journal of Kidney Diseases 
Volume 67, Pages S48-S51 (January 2005)
Lesley A. Stevens, MD, MS, Nicholas Stoycheff, MD 
Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen.
Risk factors Odds ratio 95% CI p Age >75 (referent: age 46-60) 2.17
Dr Donal O’Donoghue National Clinical Director for Kidney Care
Figure 1. (A) Composite renal outcome, (B) worsening kidney function, and (C) incident albuminuria by fasting glucose ... Figure 1. (A) Composite renal.
Clinical Background. A clinically applicable approach to continuous prediction of future acute kidney injury.
Identification of thresholds for significant renal recovery in relation to patient and renal survival. Identification of thresholds for significant renal.
Presentation transcript:

Mean changes* in SCr and GFR by treatment group and baseline renal function End point Nesiritide Placebo p Peak SCr increase (mg/dL)   All available subjects 0.15 (n=133) 0.34 (n=133) <0.001 Subjects with baseline SCr >1.2 mg/dL 0.02 (n=29) 0.48 (n=33) 0.001 Maximum decrease in GFR (mL/min/1.73 m2) -10.8 (n=133) -17.2 (n=133) -0.2 (n=29) -9.1 (n=33) 0.003 *Through discharge or hospital day 14, whichever came first SCr=serum creatinine GFR=glomerular filtration rate Hebeler RF Jr, Oz MC. 7th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke; May 9, 2006; Washington, DC. Poster 104, abstract 292.

Postoperative measures of renal function and urine output by treatment group Parameter Nesiritide Placebo p Urine output, 1st 24 hours (mL) 2926 2350 <0.001 Postoperative SCr increase >0.5 mg/dL (%) 7 23 Length of hospital stay (d) 9.1 11.4 0.043 SCr=serum creatinine Hebeler RF Jr, Oz MC. 7th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke; May 9, 2006; Washington, DC. Poster 104, abstract 292.